Trademark Attorney / Law Firm
Scott Champagne – Trademark Portfolio
Scott Champagne specializes in Class 44 (Medical Services) trademark filings before the United States Patent and Trademark Office (USPTO), with 2 of 4 total filings concentrated in this category. The practice also covers Class 41 (Education & Entertainment) along with 3 other Nice Classification classes. Filing activity spans from 2019 to 2026. Currently, 1 trademark is registered and 2 are pending.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Scott Champagne's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademark applications has Scott Champagne filed?
Scott Champagne has filed 4 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 2 pending, 1 abandoned.
What trademark classes does Scott Champagne specialize in?
Scott Champagne has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 32 (Light Beverages). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
How long has Scott Champagne been filing trademarks?
Scott Champagne's trademark filing history with the USPTO spans from 2019 to 2026, covering 7 years of trademark practice. During this period, Scott Champagne has handled 4 trademark applications.
What is Scott Champagne's trademark registration success rate?
Scott Champagne has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.